The worldwide role of ICOS
The International Cardio-Oncology Society was founded in 2009 after scientists demonstrated that cardiac side effects in patients being treated for cancer could be prevented. Years of subsequent research have demonstrated that cooperation between cardiologists and oncologists can meaningfully improve the outcomes of patients as well as their quality of life. Through promotion of training and study in cardio-oncology, ICOS has developed best practice strategies to prevent and treat cardiac toxicity in patients undergoing chemotherapy.
“It’s not just a matter of building up a society but saying to everybody that the need for working together is of paramount importance,” says Dr. Carlo Cipolla, Director of the Cardiology Division at the Institute of European Oncology (IEO) in Milan, Italy.
The only journal devoted exclusively to this emerging specialty, Cardio-Oncology provides an international forum for communicating the latest findings and state-of-the-art reviews
With vibrant membership, worldwide chapters and generous donators, the non-profit society continues to promote scientific educational activities including; monthly webinars, conferences, scholarships, seminars, and guideline development.
These educational efforts include co-hosting the Global Cardio-Oncology Summit, now in its 7th year, which features the latest research and clinical guidelines through peer-led presentations and case studies on the prevention, management and treatment of cardiac complications related to cancer therapy. The annual summit will be held this year in Tampa, FL on September 27th-28th at the Hilton Downtown with registration open until the day before the conference begins.
A new partnership
The only journal devoted exclusively to this emerging specialty, Cardio-Oncology provides an international forum for communicating the latest findings and state-of-the-art reviews, filling a critical gap in the science and clinical practice of this important field. The journal serves as essential reading for basic researchers, drug developers, adult and pediatric onco-hematologists, cardiologists, radiologists, surgical oncologists, internists, geneticists, epidemiologists, and other health care scientists and providers.
The presence of a journal related to cardio-oncology is of great importance within this field and ICOS is eager to strengthen ties to Cardio-Oncology for the betterment of its members and cardio-oncology research worldwide. Members of ICOS will receive a 10% discount on submissions to the journal.